VÉSALE BIOSCIENCE
About us
About us
Vésale Bioscience is a Belgian biotech, created in 2018 as a spin-out of Vésale Pharma thanks to its long experience in microbiotics.
We fight AntiMicrobial Resistant infections (AMR) with our personalized phage therapy solutions:
– We have developed a fast diagnostic tool Inteliphage®, an automated Phagogram, that will recommend the optimal phages association (2 or 3) to fight the patient’s bacteria.
– We produce a library of phages and deliver the selected phages as API for tailored magistral preparations. This approach dramatically increases the success rate of AMR treatments and has already been tested in more than 100 critically ill patients without major safety concerns. Our current phage library targets S.Aureus, K.Pneumoniae, E.Coli and P.Aeruginosa, responsible for 70% of AMR infections in EU & US.
Research & Development partnerships
Vésale Bioscience has a track record of successful partnerships with academic and clinical research organizations.
We have developed a broad scientific network, including the Queen Astrid Military Hospital (BE), Laboratory of Brussels University Hospitals (BE), Eliava Institute (Georgia), … and benefit from grants of the Walloon Region to develop innovative solutions for human and veterinary use.
Our success lies in our unique ability to identify novel phages across many indications, to purify, educate and produce them in the appropriate galenic to reach the targeted bacteria.
Vésale Bioscience is always interested in establishing new alliances and partnerships and welcome proposals in these areas.
We are also open to discussions with pharmaceutical companies the co-development of our innovative solutions outside of Europe or for veterinary use.
Commercial Partnerships
We are actively looking for commercial partners for our current assets. Many territories are still open for licensing/distribution agreements.
Contact for partnerships
Please submit your business development proposals via email to info@phage.health
Our team
Executive Chairman
Jehan Liénart
Founder of Vésale Bioscience and founder of Vésale Pharma.
Founded the largest Belgian marketing agency (Air) and was active chairman of the board of a contracted sales force organization.
CEO
Gunther Vanwezer
Over 25 years of experience in management positions in Life Sciences Industry and MedTech (Organ Recovery Systems, TERUMO, ThermoFisher Scientific)
Master degree in Biochemical Engineering Technology (ULeuven – Belgium) and a degree in Business Administration from the EHSAL Management School (Brussels, Belgium).
CFO
Guillaume de Viron
Part-time CFO of OncoDNA, Masthercell, Univercells, IMCYSE,… and 5 years Deloitte Consulting MSc of business
CBBDO
Gérald de Patoul
Co-founder of Oncomfort in May 2017 and acted for 4 years as Director and CFO, in charge of finance, tax, legal, insurance, human human resources, operations and quality management
CSO
Johan Quintens
Over 30 years in the pharmaceutical industry. Johan is the author of 8 patents in probiotic and phage technology. Stem from Vesale Pharma where he developed its current probiotic products ranges Johan joined Vesale Bisoscience at its foundation.
Johan holds a Master Degree in Biological Sciences from the RUGhent with an additional Specialization in Bacteriology, Endocrinology and Parasitology. He also obtained a post-university Masters in Business Management at UFSIA
CMO
Vincent Grek
Dr Vincent Grek joins Vésale Bioscience as Chief Medical Officer
Strong clinical development expertise as head of clinical development and chief medical officer.
Medical Doctor, specialized in Internal Medicine, trained in blood cancer and infectious diseases (ULiège-Belgium)- Executive MBA (ESSEC Paris – France) – Good Clinical Practice Certification 2022
CCO
Philippe Ghem
CCO of ASIT biotech and large commercial experience with Grünenthal, Novartis, GSK
Commercial Engineer (ULB) and Master in Marketing (ICHEC)
Director of External Collaborations & Corporate Compliance
France Fannes
>10 years own entrepreneurial experience in IVD market
Managing Director of BioWin, the health competitiveness cluster in Wallonia (2010-2014)
Master in Biomédical Sciences (ULB)
Head of Quality
Gontran Brichard
Over 15 years in the field of biotech and pharmaceutical industries (MD quality and regulatory,data management for clinical projects and computer system validation for GMP production)
Bachelor Degree in Pharmaceutical Sciences and a Master Degree in Molecular & Cellular Biology from the University of Namur.
Spokesman, Corporate Communication Strategy Director
Eric Louis Poskin
Over 25 years of experience in Corporate Communication Strategy and Governmental affairs with Biotech & MedTech companies.
« MA in Philosophy » (LSM – Ulouvain) and Degree in Mathematics (ISAN – Namur).
Administration & HR Director
Jacqueline Abrassart
Master in political sciences (UCL), Accounting (IFOSUP) & tax (ESA)
